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Abstract — In the post genomic era, proteomics has 
enormous potential in biology and medicine. Among the 
various bioanalytical tools developed, protein microarray is 
one of the recent advancements which offer high throughput 
profiling of cellular proteins to provide insights into the 
mechanisms of biological processes. Fundamentally, the 
protein microarray involves the immobilization of interacting 
elements, proteins, on a few square microns of a solid support 
and in principle, it is capable of detecting analytes with a 
higher sensitivity than conventional macroscopic 
immunoassays. Here in the present report we delineates the 
design, fabrication and functional analysis of protein 
microarray using semi-synthetic ssDNA tagged-proteins as 
capturing moiety as well as address on a solid support. 
Optimization of the platform has been carried out by 
investigating various parameters such as surface chemistry, 
signal amplification, and conditions for homogenous liguid 
phase protein-protein interaction. 
 
Index Terms — Proteomics, Protein micro array, 
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I. INTRODUCTION 
uring the last decade DNA microarray has been 
instrumental in probing the global transcriptome of 
the cells.1-3 Followed by protein microarray which has 
emerged as another complimentary approach for high 
throughput analysis to understand the complex cellular 
system.4 Currently, there are many different strategies for 
the fabrication and functional analysis of protein 
microarray.5-6 Fundamentally these microarray formats 
stems on different immobilization chemistry, detection 
methodology or capturing of the analyte. Nevertheless, all 
of the protein arrays can be classified as either forward 
phase (antibody or any capturing entity immobilized onto 
surface) or reverse phase array (antigens immobilized onto 
the surface and probe the respective antibody). Many 
different types of proteins could be simultaneously 
detected on the same chip. Despite these successes of 
protein microarray in profiling the proteome of the cell, it 
has many inherent limitations which are still unresolved and 
prevent protein microarray technology from reaching its full 
potential.7 Some of these limitation includes the generation of 
content ie probe for complete proteome analysis, the conservation 
of protein functionality during the immobilization, as well as the 
provision of the required absolute and relative sensitivity. 
Even though protein and nucleic acid microarrays were 
technologically similar in many aspects, the most significant 
differences are found in the physical properties and 
stability of soluble proteins and DNA at interfaces. Unlike 
DNA, proteins are chemically and physically 
heterogeneous, have a three-dimensional structure which is 
critical to their function, and have no analogous 
amplification technique. Many proteins are also known to 
adsorb non-specifically to commonly used substrates and 
pose a constant problem in generating false positive 
signals. These factors can compromise the performance of 
protein microarrays and limit its specificity and sensitivity, 
particularly when complex biological fluids are used. In 
addition, surface modifications provide homogenous and 
efficient activation of the entire surface of the substrate 
used. Thus, the surface chemistries must be chemically and 
physically robust. Herein, we describe the design, 
fabrication and use of a PAMAM modified glass surface 
for the generation of a robust, homogenous chemically 
activated and high density substrate which is useful for 
protein microarrays. In addition, we designed and 
fabricated a new platform, spatially addressable protein 
array (SAPA), by exploring the specificity of ssDNA 
hybridization for a self-assembly of semi-synthetic ssDNA-
antibody conjugates which captured the antigen from 
complex biological samples. 
II. EXPERIMENTAL SECTION 
Materials and instrumentations. The carboxyl-
terminated PAMAM (10% solution in methanol), N-
hydroxysuccinimide (NHS), succinic anhydride, 4-
hydroxy-3-nitrobenzenesulfonic acid (HNSA), 
polyethylene oxide (PEO, 100,000 Mwt) and Sephadex 
G50 were obtained from the Sigma and 1-Ethyl-3-(3-
Dimethylaminopropyl)carbodiimide hydrochloride (EDC) 
were purchased from Pierce Chemicals. The diamino 
polyethylene glycole (PEG, 3400 Mwt) was obtained from 
Nektar Therapeutics, CA, USA.  Cy5 fluorescent mono-
reactive dye was purchased from Amersham Biosciences. 
The amine and epoxy slides were from Genetix in UK. The 
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mouse monoclonal anti-EGFP (Molecular Probes) and 
TRITC-labelled rabbit IgG (DakoCytomation, USA) were 
purchased and purified using a Pierce protein A/G column 
according to manusfacturer’s instructions. eGFP was 
obtained from Upstate, USA. Laser scanning was carried 
out on the GenePix 4000B (Axon Instruments CA, USA). 
Fluorescence spectrophotometry was carried out on the 
Fluorostar Optima (BMG Labtechnologies GmbH, 
Germany) and atomic force microscopy using the 
Nanoscope III (Digital Instrument Int.)  
Preparation of carboxyl-terminated dendrimer-
functionalized glass slides. Carboxyl-terminated PAMAM 
dendrimer slides were prepared using amino-silylated glass 
slides. The carboxylic acid of the PAMAM dendrimer was 
activated with a solution of EDC/NHS (1:1, 100 mM) in 
0.1 M MES (pH 6.3), layered onto the amine slides and 
incubated for 2 h. The slides were then washed with double 
distilled water, ethanol and air dried. The slides were then 
kept in vaccuo until use. The carboxyl-terminated 
PAMAM slides were further activated by EDC/HNSA or 
EDC/NHS active ester (1:1; 100 mM) in 0.1 M MES, 0.5 
M NaCl (pH 6.3) buffer. The activated slides were washed 
with double distilled water, ethanol and air dried by 
centrifugation. The slides were stored in desiccators under 
nitrogen at room temperature until use. 
Cell culture and lysate extraction. The Neuro 2A cell 
line (CCL-131) was obtained from ATCC. The cells were 
grown at 37 °C in a 5% CO2 atmosphere in DMEM 
medium (Gibco/Life Technologies) supplemented with 
10% fetal calf serum, 100 units/mL penicillin, and 100 
µg/mL streptomycin. At 90% confluency, the cells were 
washed twice with 1x phosphate buffered saline (1x PBS) 
and lysed with 1x PBS, 0.5% Triton X-100.  The lysate 
was subsequently cleared by centrifugation and the 
supernatant containing the cellular proteins recovered for 
labeling. 
Labeling of cell lysate and eGFP. The cell lysates or 
eGFP were labeled with Cy5 mono-reactive dye according 
to the recommended procedure by the manufacturer. The 
protein samples were diluted to 0.5 mg/mL in labeling 
buffer (0.1 M NaCO3, 50 mM NaCl, pH 9). The diluted 
protein solution was incubated with Cy5-NHS dye (4 µg/µl 
in DMSO) with a protein-dye ratio of 1:1 (w/w) with 
intermittent shaking at at 25 oC for 30 min. The reaction 
was then quenched using Tris-HCl (0.1 M, pH 8) for 10 
min.  Free dye was removed by size exclusion 
chromatography (Sephadex G50) pre-equilibriated in 1x 
PBS, pH 7.4. Concentration of the eluted protein was 
measured using the microBCA kit from Pierce. 
Immobilization of antibodies onto slides and capturing 
of labeled antigen. Antibodies in the printing buffer (1% 
glycerol, 5 mM EDTA in 1x PBS at pH 8) were spotted 
(500 nL each) onto the pre-activated PAMAM or epoxy 
slides. The coupling reaction was allowed to proceed for 4 
hours at 250C in a humid chamber. The arrayed slides were 
then washed 3x in buffer containing 1x PBS and 0.05% 
Tween 20 (wash buffer), each for 10 min.  The arrayed 
slides were then incubated in blocking buffer (1x PBS 
containing 3% Tween 20, 5% Trehalose and 0.1% NaN3) 
for 30 min followed by incubation with 20 µL of varying 
concentrations of eGFP-Cy5 or cell lysates in 1x PBS, 
0.1% TX-100, 1% or 10% non- milk solution in a humidity 
chamber at 250C for 1 h in the dark. The slides were then 
incubated in wash buffer for 10 minutes (3 times) and spun 
dried. The slides were then imaged and results analyzed 
using GenePix 3.0 software (Axon Instruments, Union 
City, CA). 
Immobilization of H2N-ssDNA over the activated 
dendrimer and succinamic acid slides. For the covalent 
attachment of the H2N-ssDNA, typically 500 nl of a 
solution of the 5′-amino-modified oligonucleotide in 0.1 M 
NaHCO3 (pH 8.5) was arrayed on to the HNSA-activated 
slides and incubated for 3 h in a humid chamber. The slides 
were washed with water and subsequently incubated in 
solution of 1 M Tris buffer (pH 9) for another 1 h at 42 C 
to quench all the remaining activated groups. After a 
thorough wash with water, the slides were dried by 
spinning in a centrifuge with a slide holder (500 rpm 5 min 
at 27 C) and further dried under a stream of nitrogen. 
Synthesis of ssDNA-antibody conjugates. ssDNA-
antibodies conjugates were synthesized using a modified 
reported procedure.8 The sulfhydryl group of a modified 
FAM-labeled oligo 5′FAM-(CH2)6-(T)20-3′(CH2)6-SH was 
linked using a bifunctional cross-linker, sulfo-SMCC, to 
the amine group on the surface of the antibody. To 
optimize and quantify each step TRITC-labeled rabbit anti-
IgG and the FAM-labeled ssDNAs were used. To generate 
a free sulfhydryl group the protected thiol-modified 
oligonucleotides were decapped by reduction of the 
disulfide bond (10 mM DTT) and purified by precipitation 
with acetone. The  purified TRITC-labeled rabbit anti-IgG 
was reacted with the sulfo-SMCC cross-linker at a 1000 
molar excess in phosphate buffered saline (1xPBS, pH 7.4) 
for 30 min at room temperature. Unreacted cross-linker 
was removed using a Pierce protein desalting column. The 
yield of the cross linker attached antibody was quantified 
by measuring the fluorescence of the TRITC (~70%). 
Purified products were reacted with thiol-modified 
oligonucleotide in a 1:10 molar equivalent (1 h,    4 οC). 
Further incubation at 37 οC (20 min) was performed to 
reduce the non-specific binding of antibody onto the 
appendorf tube. The excess oligonucleotides were 
separated from the conjugates by non-denaturing PAGE 
(20% 19:1) at 120 V for 10 min. The conjugates which had 
not migrated into the gel were recovered from the well. 
These conjugates were diluted in 1x PBS (pH 8) solutions 
and stored at 4 °C. Product yields were quantified by 
measuring the fluorescence intensity of the FAM in the 
oligo and TRITC in the antibody.  Approximately 4 
molecules of ssDNAs were conjugated to one molecule of 
the antibody by using FAM-labeled oligo to quantify the 
oligo incorporation at the final stage and micro BCA to 
quantify the antibody. 
Investigation of the loading capacity of the slides by 
immobilization of Cy5-labeled oligo and hybridization 
of ssDNA-TRITC labeled IgG antibody conjugate. To 
 
 
quantify and compare the loading capacity of the oligo 
address, on PAMAM-carboxyl and succinamic acid 
derivatized slides, amino-modified Cy5-labeled ssDNA 
(5′NH2-(CH2)6-(T)20-3′ (CH2)6-Cy5) with concentrations 
of 10, 20, 30, 40, 60, 80 µmole/L (0.1 M Na2CO3, pH 9) 
were spotted onto a pre-activated glass slide and incubated 
for 2 hrs in a humid chamber and processed as described in 
the oligo immobilization procedure. The loading of the 
labeled oligos were checked by measuring the fluorescence 
intensity using a GenePix 4000, Axon laser scanner. 
To quantify and compare the amount of captured ssDNA-
tagged antibody, the slides were prepared by loading with 
different concentrations (10, 20, 30, 40, 60, 80 µmole/L) of 
complimentary (3′NH2-(CH2)6-(2T)20-5′) and non-
complimentary (5′NH2-(CH2)6-(2A)20-3′) ssDNA. After 
quenching and washing, 5’FAM-(CH2)6-(2T)20-
3(CH2)6SH-oligo tagged TRITC labeled IgG antibody in 
1xPBS pH 7.4 with 0.1% milk and  0.1% TX 100 at pH 7.4 
(20 µL, 2 pmole) is incubated using a cover slip. Incubated 
for 1 hr to capture the ssDNA- IgG over the complimentary 
ssDNA spotted glass slide, washed with 0.1% TX 100 in 
1xPBS pH 7.4 at pH 7.4 (30 min), 1xPBS pH 7.4 (1 min) 
and were dried by spinning in a centrifuge with a slide 
holder (500 rpm 5 min at 27 οC) and further dried under a 
stream of nitrogen. The fluorescence intensity of the 
hybridized antibody was measured using a GenePix 4000, 
Axon laser scanner. 
III. RESULTS AND DISCUSSION 
Surface chemistry. In the protein/antibody micro array the 
major objective is the study of interaction partners. Thus, 
the key requirements are high binding capacity of 
interaction entity yet with low nonspecific protein 
background and low variability. There have been numerous 
studies to identify an optimal surface protein array. The 
surfaces used for protein array were divided as three 
classes, (i) two-dimensional plain glass slides which are 
activated with a variety of coupling chemistries such as 
aldehyde, epoxy or carboxylic esters,9 (ii) three 
dimensional (3D) gel or membrane-coated surfaces such as 
polyacrylamide, agarose and nitrocellulose110-13 and (iii) 
surface coatings, such as PEG, BSA, avidin and dendrimer 
over the 2D glass slides.14  In 2D glass surfaces proteins or 
antibodies bind either by electrostatic interactions or 
through covalent linkages which offers strong attachment 
combined with low variation. However, the limitations 
such as rapid evaporation of the liquid environment as well 
as the close surface contact may lead to the denaturation of 
native structure of the protein. Where as in the 3D gel or 
membrane surfaces, proteins bind through physical 
adsorption and have better preservation of the native 
protein conformation. However, due to the lack of specific 
binding of the proteins often leads to leaching and large 
variations in the signal intensity. In principle the third 
group of surface coatings has the advantages of both 2D 
and 3D surfaces mentioned above. Although the 3D 
structures are not visible, the coating of large 
macromolecules generated supramolecular structure on the 
surfaces provides an interface which is more compatible 
for minimizing the protein denaturation and specific 
binding on the surfaces. Among the various 
macromolecule coated surfaces, dendrimers is a unique 
class of polymer that differs from linear polymers in that 
they don't have entangled chains and at the same time have 
numerous chain-ends that can be easily functionalized. 
Previously, poly(amidoamine) (PAMAM) dendrimers with 
highly uniform and compact amine linkers have been 
exploited for various applications in high density DNA 
microarrays and protein immobilization studies.15-16 In the 
present study we explored the single-step chemical 
coupling of a PAMAM-carboxyl dendrimer (3.5G, 64 
carboxyl groups) to generate quasi three dimensional 
nanostructured monolayer on amino-silylated glass slides 
(Fig. 1a). It is anticipated that these newly fabricated 
surfaces are homogenous, with a high density of carboxyl 
functional groups. A comparison of different surfaces was 
performed for the nonspecific protein adsorption as well as 
protein immobilization. As expected the, the non-specific 
protein adsorption on carboxyl terminated PAMAM slides 
is almost same as to a PEG modified linear linker such as 
epoxy surface (Fig. 1b).   
 
Fig. 1: (a) Tapping mode AFM height images (10 × 10 µm) 
of the dendrimer coated slides. (b) Nonspecific protein 
adsorption of the Cy5 dye labelled cell lysate over various 
chemically modified glass slides 
Besides the provision of an optimum surface which has 
low nonspecific protein adsorption, the optimal 
immobilization of probe protein/antibody on the surface 
and the optimization of assay conditions and the detection 
sensitivity of analytes is another key parameter of every 
micro array technology. In order to validate the 
performance of the carboxyl terminated PAMAM slides, 
the slide surface was further pre-activated with 
EDC/HNSA and immobilized with different concentration 
(1-100 µg/mL) of monoclonal anti-eGFP antibody. Similar 
concentrations of the antibodies were immobilized over a 
linear linker 2D epoxy slide for comparison. The antigen, 
eGFP labeled with Cy5 (0.2 pmol/µl), was then incubated 
and captured on the arrays. The signal intensity was 
significantly greater on the PAMAM slides than the epoxy 
slides (Fig. 2). The result is consistent with the proposition 
that dendrimers not only increased the density of functional 
sites but was also highly accessible to analytes which is 
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more comparable to the properties of 3D gel or membrane 
coated slides. 
Dendrimer slide
Epoxy slide
5 10 25 50 100
Conc. of Antibody (µg/mL)  
Fig. 2: Comparison of the antigen captured by antibody 
immobilized on a PAMAM carboxyl slides and epoxy 
slides 
ssDNA-tagged antibody and addressable protein array. 
The high loading capacity of ssDNA on carboxyl 
terminated PAMAM slides was further evaluated. In order 
to compare the efficiency of hybridization linear linker 
succinamic acid slides was used for comparison. Initially, a 
doubly functionalized ssDNA was serially diluted and 
arrayed (500 nl, 5′NH2-(CH2)6-(T)20-3′ (CH2)6-Cy5 in 
0.1M Na2CO3, pH 8-8.5) onto pre-activated PAMAM 
carboxyl and succinamic acid slides. After 3 hours of 
incubation in a humid chamber, the unbound ssDNA was 
removed by washing in water and the remaining activated 
groups quenched by incubating the slides in 1 M Tris for 1 
h. The observed fluorescence intensity showed that 
dendrimer-coated slides have higher loading capacity of 
ssDNA compared to the linear linker succinamic acid 
slides.  
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Fig. 3: The amount of 20-mer ssDNA (5′NH2-(CH2)6-(T)20-
3′ (CH2)6-Cy5) immobilized on to PAMAM carboxyl and 
succinamic acid surfaces. 
The DNA-tagged antibodies were prepared using a 
bifunctional linker Sulfo-SMCC attached to the surface 
amine group of TRITC-labeled polyclonal Swine anti-
rabbit IgG (ARIgG), followed by electrophilic addition of 
the thiol group in a 20-mer modified ssDNA, 3′SH-(CH2)6-
(T)20-(CH2)6 FAM 5′, to the maleimides in the SMCC. 
Excess ssDNA was removed and the conjugate was 
purified by non-denaturing PAGE (20% 19:1). Purity of 
the ssDNA-tagged antibodies was further confirmed by 
loading into an agarose gel (1%). The calculated yield 
using the FAM-labeled ssDNA incorporated onto the 
antibody showed that on average, 4 molecules of ssDNA 
were conjugated to a molecule of IgG. The amount of 
protein was quantified by microBCA analysis and the final 
yield of the product was found to be ~60%, which is 5-6 
times more than the yield achieved by previously reported 
procedures. 
 
Fig. 4: Schematic representation of bifunctional cross 
linker SMCC mediated conjugation of ssDNA to TRITC-
labeled polyclonal Swine anti-rabbit IgG (ARIgG) . 
The hybridization of ssDNA-tagged antibodies were 
investigated using ssDNA (3′NH2-(CH2)6-(T)20-5′ and 
3′NH2-(CH2)6-(A)20-5′) (10, 20 30 40 and 50 µM) arrayed 
on carboxyl terminated PAMAM slides using ssDNA 
(3′HS-(CH2)6-(T)20-(CH2)6 FAM5′) conjugated TRITC -
ARIgG. The observed results showed that the amount of 
ssDNA-TRITC-ARIgG hybridized on the complimentary 
ssDNA arrays increased with increasing concentration of 
the oligonucleotide on the dendrimer slides and saturated at 
30 µM of oligonucleotides spotted on the slides (data not 
shown). This indicates that steric hindrance from the 
ssDNA-IgG conjugate would influence the efficiency of 
hybridization onto the complementary ssDNA arrayed on 
the slides. In addition the concentration dependent 
hybridization of ssDNA-TRITC-ARIgG (5, 10, 20, 50 
µg/mL) showed that that the hybridization was increasing 
linearly with concentration and did not reach saturation 
even at a concentration of 50 µg/mL of the conjugate (Fig. 
4).  
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Fig. 5: The amount of ssDNA-ARIgG hybridized from 5, 
10, 20 and 50 µg/mL ssDNA-TRITC_ARIgG on a 30 µM 
SH+ +
ssDNA TRITC- ARIgG SMCC 
 
 
ssDNA arrayed slides. 
The amount of ssDNA-TRITC-ARIgG hybridized on 
surface decreased dramatically as the conjugate 
concentration dropped below 10 µg/mL. This indicates that 
the hybridization of the ssDNA-antibodies has a significant 
influence on the signal intensity when compared to the 
ssDNA-antibodies to antigens ratio in the capturing 
medium. From the aforementioned observation, we fixed 
the concentration of the ssDNA-antibody capturing probe 
at 20 µg/mL for subsequent experiments. In order to 
optimize the concentration of conjugates in the solution, 
we titrated different concentrations of ssDNA-IgG (1, 5, 
10, 20, 50 µg/mL) against 0.1 µg/mL rabbit IgG (labeled 
with Cy5) in the capturing medium (Fig. 5). The observed 
results showed that very good signal intensity with high 
signal to noise was observed even at very low antigen 0.1 
µg/mL antigen concentrations which indicated the 
combined effect of the higher efficiency of the probes 
hybridizing onto the immobilized ssDNA on the high 
density dendrimer substrate (Fig. 5). 
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Fig. 5: Capturing efficiency of 0.1 µg/mL antigen in 
different concentrations of ssDNA-TRITC-ARIgG in the 
capturing solution (1, 5, 10, 20, 50 µg/mL) on a 30 µM 
oligo spotted slide. 
We have performed a detection sensitivity assay for the 
newly designed array format by capturing antigen Cy5-
labeled rabbit IgG of different concentrations (50, 500, 
5000, 5000 pM) using a ssDNA-tagged swine anti-rabbit 
IgG (SAR-IgG) (20 µg/mL) on complimentary ssDNA-
arrayed slides (Fig 6). The observed detection limit was 1 
pM of the antigen with the signal-to-noise ratio of ~30. 
This shows the efficiency of the new approach of DNA-
directed assembly (DDA) in the detection of low amounts 
of antigen (50 pM) with significantly lower concentrations 
of the capture reagent (0.001 µM). Recently, similar 
studies explored the DNA direct immobilization by 
Wacker et al.6 reported highest signal intensities with best 
spot homogeneity and reproducibility as well as the lowest 
consumption of antibodies. However, the additional effort 
involving multistep preparation of ssDNA tagged 
streptavidin and preparation of conjugate for each antibody 
will result in lower yield. With DDI, immobilization and 
capturing of antigen method still has the problems of 
denaturation of immobilized antibody and the antibody 
orientation on array surface which are common hurdle in 
the antibody immobilized arrays also. In contrast, our new 
array system offers the capturing of the antigen in solution, 
followed by the highly efficiently assembly conjugated 
over a highly compatible dendrimer modified slides.  
 
R
FU
Conc. of Antigen (pM)
10
10000
10 100 1000 10000 100000
R
FU
 
Fig. 6. Different concentrations of antigen-rabbit IgG, 
captured with 10 µg/mL ssDNA-SARIgG, using 30 µM 
oligo spotted slide. 
IV. CONCLUSIONS 
In summary, the present study described a simple, 
efficient fabrication of a novel antibody micro array 
format. The performance of newly fabricated surface and 
array format for antibody microarray was evaluated in 
terms specificity and sensitivity. 
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